Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lisofylline inhibitor of phosphatidic acid: Update

Cell Therapeutics Inc., Seattle, Wash.
Product: Lisofylline inhibitor of phosphatidic acid
Indication: Neutropenia and

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE